Moderna says it could have an RSV vaccine as soon as next year


Moderna Inc. said on Thursday morning that its vaccine for respiratory syncytial virus, better known as RSV, could be ready for commercialization as soon as next year.

Previous A view of Measure 110 from a peer mentor who is 6 years clean
Next Atlanta-based Papa Johns CEO Rob Lynch: Permitting delays are dogging growth